Literature DB >> 18390410

Unraveling the biology of multiple myeloma disease: cancer stem cells, acquired intracellular changes and interactions with the surrounding micro-environment.

Jo Caers1, Els Van Valckenborgh, Eline Menu, Benjamin Van Camp, Karin Vanderkerken.   

Abstract

Cancerogenesis is believed to be a multistep process composed of different alterations that drive the transformation of normal human cells into highly malignant derivatives. These changes include self-sufficiency in growth signals, insensitivity to growth-inhibitory signals, the evasion of programmed cell death, a limitless replicative potential, sustained angiogenesis, and tissue invasion and metastasis. Some evidence suggests that these cancer cells are derived from immature, proliferative precursors that feed the cancer cell compartment. Both, precursors and cancer cells, intensively interact with their surroundings, commonly described as their micro-environment. The processes above are also important in the biology of multiple myeloma, a malignant bone marrow disorder consisting of monoclonal plasma cells accumulation. In the current review we describe the biology of this disease, stressing the origin of myeloma cells, their acquired genetic changes and interactions with their bone marrow microenvironment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18390410     DOI: 10.1684/bdc.2008.0600

Source DB:  PubMed          Journal:  Bull Cancer        ISSN: 0007-4551            Impact factor:   1.276


  20 in total

1.  SGK3 (CISK) may induce tumor angiogenesis (Hypothesis).

Authors:  Minzhi Hou; Yingrong Lai; Shanyang He; Weiling He; Hongwei Shen; Zunfu Ke
Journal:  Oncol Lett       Date:  2015-05-06       Impact factor: 2.967

2.  Dosimetry results suggest feasibility of radioimmunotherapy using anti-CD138 (B-B4) antibody in multiple myeloma patients.

Authors:  Caroline Rousseau; Ludovic Ferrer; Stéphane Supiot; Manuel Bardiès; François Davodeau; Alain Faivre-Chauvet; Pierre Baumgartner; John Wijdenes; Marie Lacombe; Jacques Barbet; Thierry Guillaume; Philippe Moreau; Jean Luc Harousseau; Françoise Kraeber-Bodéré; Michel Cherel
Journal:  Tumour Biol       Date:  2012-03-03

3.  The ubiquitin-proteasomal system is critical for multiple myeloma: implications in drug discovery.

Authors:  Biyin Cao; Xinliang Mao
Journal:  Am J Blood Res       Date:  2011-05-25

Review 4.  Biological aspects of angiogenesis in multiple myeloma.

Authors:  Eléonore Otjacques; Marilène Binsfeld; Agnes Noel; Yves Beguin; Didier Cataldo; Jo Caers
Journal:  Int J Hematol       Date:  2011-11-17       Impact factor: 2.490

5.  NF-Kβ Activation in U266 Cells on Mesenchymal Stem Cells.

Authors:  Sara Zahedi; Karim Shamsasenjan; Aliakbar Movassaghpour; Parvin Akbarzadehlaleh
Journal:  Adv Pharm Bull       Date:  2016-09-25

6.  Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1.

Authors:  Tomohiro Umezu; Hiroko Tadokoro; Kenko Azuma; Seiichiro Yoshizawa; Kazuma Ohyashiki; Junko H Ohyashiki
Journal:  Blood       Date:  2014-10-15       Impact factor: 22.113

7.  Thymosin β4 has tumor suppressive effects and its decreased expression results in poor prognosis and decreased survival in multiple myeloma.

Authors:  Jo Caers; Dirk Hose; Ine Kuipers; Tomas Jan Bos; Els Van Valckenborgh; Eline Menu; Elke De Bruyne; Hartmut Goldschmidt; Ben Van Camp; Bernard Klein; Karin Vanderkerken
Journal:  Haematologica       Date:  2009-10-14       Impact factor: 9.941

8.  Curcumin in combination with bortezomib synergistically induced apoptosis in human multiple myeloma U266 cells.

Authors:  Juwon Park; Vasudevan Ayyappan; Eun-Kyung Bae; Chansu Lee; Byung-Su Kim; Byoung Kook Kim; Young-Yiul Lee; Kwang-Sung Ahn; Sung-Soo Yoon
Journal:  Mol Oncol       Date:  2008-10-07       Impact factor: 6.603

9.  Serum 8-isoprostane levels and paraoxonase 1 activity in patients with stage I multiple myeloma.

Authors:  Yousef Faridvand; Ali Eishi Oskuyi; Mohammad-Hassan Khadem-Ansari
Journal:  Redox Rep       Date:  2016-02-26       Impact factor: 4.412

Review 10.  Cancer invasion and metastasis: interacting ecosystems.

Authors:  Marc Mareel; Maria J Oliveira; Indira Madani
Journal:  Virchows Arch       Date:  2009-05-27       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.